How Long Do AIDP Symptoms Take to Peak? Full Timeline

For Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP), the period of worsening symptoms usually lasts between a few days and four weeks ^[1]. Once your condition reaches its worst point—a medical milestone called the nadir—the progression of your measurable weakness generally plateaus. Research shows that most patients reach this nadir within two weeks of their first symptoms ^[2], with average onset-to-nadir times around 7 days ^[3]. By the four-week mark, the progression of weakness has stabilized for nearly everyone with standard AIDP ^[1]. However, these are population averages, and individual timelines can vary.

⚠️ SAFETY WARNING: Do not wait for a predicted nadir.
Reaching a plateau in your limb strength does not guarantee that other dangerous symptoms cannot occur. If you experience any new or worsening shortness of breath, a weak cough, difficulty swallowing or speaking, choking, fainting, rapidly increasing weakness, or major heart palpitations, seek immediate emergency medical assessment.

Understanding the Clinical Nadir

The sudden, rapid loss of strength or sensation in AIDP is often the most terrifying part of the condition. Neurologists closely monitor you during this time to identify your nadir—the absolute lowest point of physical function before the condition stabilizes.

It is important to understand that the “nadir” is a clinical label usually recognized in hindsight after repeated examinations. Reaching the nadir means your measurable weakness has plateaued for the time being, but it does not mean your body has immediately healed ^[2]. The recovery phase—where nerves repair their protective myelin coating and underlying nerve fibers (axons) recover—takes weeks, months, or sometimes longer. Additionally, pain, numbness, severe fatigue, and autonomic symptoms (like blood pressure fluctuations) can follow entirely different timelines than muscle weakness.

The 4-Week Rule and A-CIDP

The typical timeline of symptom progression is used by doctors to help confirm your diagnosis. In standard Guillain-Barré syndrome (which includes the AIDP subtype), the active worsening phase is defined as taking four weeks or less ^[1].

The period between 4 and 8 weeks is considered a diagnostic gray zone. If your weakness continues to steadily progress without interruption beyond 8 weeks, it strongly suggests you might not have standard AIDP. Instead, your medical team will evaluate you for a closely related condition called Acute-onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy (A-CIDP) ^[4]. While A-CIDP looks nearly identical to AIDP in the early weeks, a confirmed A-CIDP diagnosis eventually requires different, individualized long-term maintenance treatments, such as corticosteroids or ongoing intravenous immunoglobulin (IVIG) ^[4].

Treatment-Related Fluctuations (TRF)

There is an important exception to the standard timeline. Between 8% and 16% of patients experience a treatment-related fluctuation (TRF) ^[5][6].

A TRF occurs when a patient receives standard treatments—like IVIG or plasma exchange (PLEX)—stabilizes or begins to improve, but then experiences a relapse of worsening symptoms ^[6]. A fluctuation does not automatically mean that you have A-CIDP or that the initial treatment completely failed. However, a new decline requires prompt medical assessment to distinguish a TRF from respiratory complications, an infection, or another diagnosis ^[5]. Your neurologist will evaluate your specific situation to determine if an additional round of individualized treatment is safe and necessary.